CDC's Opioid Final Guideline Narrows Duration Of Use For Chronic Pain
This article was originally published in The Pink Sheet Daily
Executive Summary
Three days of opioid use for acute pain 'will often be sufficient' and more than seven days 'will rarely be needed;' NEJM editorial by CDC officials emphasizes risks of opioid use.
You may also be interested in...
Opana ER Panel Urged To Disregard ‘Invalid’ Human Abuse Liability Study
In unusual public hearing, Edwin Thompson, head of the US firm that contract manufactures Endo’s long-acting opioid, tells US FDA advisory committee that intranasal ‘liking’ study violated FDA requirements. Thompson has petitioned the agency to do away with need for human abuse liability studies entirely, asserting they are inherently flawed.
iPLEDGE REMS: FDA Panel To Consider Changing Pregnancy Testing, Counseling Requirements
Advisory committee to discuss proposed changes to isotretinoin REMS to minimize burden and treatment delays while preventing risk of fetal exposure. Agency recommends against at-home pregnancy tests.
Biopharma Industry Sharply Divided Over Supreme Court Antibody Patent Brawl
Big biologic makers line up on opposite sides of dispute between Amgen and Sanofi over whether Amgen’s Repatha patents cover analogous antibodies with the same functional characteristics.